- Home
- AVIR vs NECB Comparison
AVIR vs NECB Comparison
Compare AVIR & NECB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- NECB
- Stock Information
- Founded
- AVIR 2012
- NECB 1934
- Country
- AVIR United States
- NECB United States
- Employees
- AVIR N/A
- NECB N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- NECB Savings Institutions
- Sector
- AVIR Health Care
- NECB Finance
- Exchange
- AVIR Nasdaq
- NECB Nasdaq
- Market Cap
- AVIR 290.4M
- NECB 282.4M
- IPO Year
- AVIR 2020
- NECB N/A
- Fundamental
- Price
- AVIR $3.14
- NECB $20.70
- Analyst Decision
- AVIR Hold
- NECB
- Analyst Count
- AVIR 1
- NECB 0
- Target Price
- AVIR $6.00
- NECB N/A
- AVG Volume (30 Days)
- AVIR 399.6K
- NECB 59.8K
- Earning Date
- AVIR 11-06-2025
- NECB 10-27-2025
- Dividend Yield
- AVIR N/A
- NECB 3.88%
- EPS Growth
- AVIR N/A
- NECB N/A
- EPS
- AVIR N/A
- NECB 3.29
- Revenue
- AVIR N/A
- NECB $103,145,000.00
- Revenue This Year
- AVIR N/A
- NECB $1.90
- Revenue Next Year
- AVIR N/A
- NECB $6.93
- P/E Ratio
- AVIR N/A
- NECB $6.27
- Revenue Growth
- AVIR N/A
- NECB N/A
- 52 Week Low
- AVIR $2.46
- NECB $19.75
- 52 Week High
- AVIR $4.02
- NECB $31.72
- Technical
- Relative Strength Index (RSI)
- AVIR 52.91
- NECB 46.05
- Support Level
- AVIR $2.78
- NECB $20.02
- Resistance Level
- AVIR $2.94
- NECB $21.30
- Average True Range (ATR)
- AVIR 0.10
- NECB 0.54
- MACD
- AVIR 0.04
- NECB 0.03
- Stochastic Oscillator
- AVIR 90.79
- NECB 36.93
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About NECB NorthEast Community Bancorp Inc.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.